155 related articles for article (PubMed ID: 34827719)
21. Histopathological Spectrum and Immunohistochemical Profile of Lung Carcinomas: A 9-Year Study from a Tertiary Hospital in North India.
Bhatti V; Kwatra KS; Puri S; Calton N
Int J Appl Basic Med Res; 2019; 9(3):169-175. PubMed ID: 31392181
[TBL] [Abstract][Full Text] [Related]
22. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH
Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792
[TBL] [Abstract][Full Text] [Related]
24. Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Carbone M; Shimizu D; Napolitano A; Tanji M; Pass HI; Yang H; Pastorino S
Oncotarget; 2016 Sep; 7(37):59314-59321. PubMed ID: 27447750
[TBL] [Abstract][Full Text] [Related]
25. [The role of the immunohistochemical marker p40 in the differential diagnosis of adenocarcinoma and nonkeratinizing squamous cell cancer of the lung].
Olyushina EM; Byakhova MM; Zavalishina LE; Andreeva YY; Semenova AB; Frank GA
Arkh Patol; 2020; 82(5):50-56. PubMed ID: 33054032
[TBL] [Abstract][Full Text] [Related]
26. A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens.
Montezuma D; Azevedo R; Lopes P; Vieira R; Cunha AL; Henrique R
Virchows Arch; 2013 Dec; 463(6):749-54. PubMed ID: 24126803
[TBL] [Abstract][Full Text] [Related]
27. [Identification of an optimal algorithm for effective diagnostics of non-small cell lung cancer with ALK gene rearrangement - implementation of the method and practical experiences with routine diagnostics].
Rozkoš T; Ryška A; Nová M; Hornychová H; Krbal L; Matěj R; Laco J
Cesk Patol; 2017; 53(2):89-96. PubMed ID: 28597670
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
Srodon M; Westra WH
Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
[TBL] [Abstract][Full Text] [Related]
29. Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?
Derks JL; Dingemans AC; van Suylen RJ; den Bakker MA; Damhuis RAM; van den Broek EC; Speel EJ; Thunnissen E
Histopathology; 2019 Mar; 74(4):555-566. PubMed ID: 30485478
[TBL] [Abstract][Full Text] [Related]
30. Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype.
da Cunha Santos G; Lai SW; Saieg MA; Geddie WR; Pintilie M; Tsao MS; Boerner SL; Hwang D
Lung Cancer; 2012 Sep; 77(3):501-6. PubMed ID: 22656670
[TBL] [Abstract][Full Text] [Related]
31. Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.
Pelosi G; Haspinger ER; Bimbatti M; Leone G; Paolini B; Fabbri A; Tamborini E; Perrone F; Testi A; Garassino M; Maisonneuve P; de Braud F; Pilotti S; Pastorino U
Int J Surg Pathol; 2014 Apr; 22(2):136-48. PubMed ID: 24326823
[TBL] [Abstract][Full Text] [Related]
32. How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung Cancer Working Party.
Thomas JS; Lamb D; Ashcroft T; Corrin B; Edwards CW; Gibbs AR; Kenyon WE; Stephens RJ; Whimster WF
Thorax; 1993 Nov; 48(11):1135-9. PubMed ID: 8296258
[TBL] [Abstract][Full Text] [Related]
33. Rapid Immunohistochemistry With Thyroid Transcription Factor-1 for Pulmonary Adenocarcinoma.
Konno H; Saito H; Nanjo H; Hiroshima Y; Kurihara N; Fujishima S; Atari M; Sato Y; Motoyama S; Nakamura R; Akagami Y; Minamiya Y
Ann Thorac Surg; 2017 Aug; 104(2):471-476. PubMed ID: 28527968
[TBL] [Abstract][Full Text] [Related]
34. PD-L1 expression in non-small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens.
Heymann JJ; Bulman WA; Swinarski D; Pagan CA; Crapanzano JP; Haghighi M; Fazlollahi L; Stoopler MB; Sonett JR; Sacher AG; Shu CA; Rizvi NA; Saqi A
Cancer Cytopathol; 2017 Dec; 125(12):896-907. PubMed ID: 29024471
[TBL] [Abstract][Full Text] [Related]
35. ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.
Zhao W; Wang H; Peng Y; Tian B; Peng L; Zhang DC
Int J Clin Exp Pathol; 2014; 7(7):4247-53. PubMed ID: 25120805
[TBL] [Abstract][Full Text] [Related]
36. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
37. A single EBUS-TBNA procedure can support a large panel of immunohistochemical stains, specific diagnostic subtyping, and multiple gene analyses in the majority of non-small cell lung cancer cases.
Rooper LM; Nikolskaia O; Carter J; Ning Y; Lin MT; Maleki Z
Hum Pathol; 2016 May; 51():139-45. PubMed ID: 26980023
[TBL] [Abstract][Full Text] [Related]
38. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.
Thunnissen E; Borczuk AC; Flieder DB; Witte B; Beasley MB; Chung JH; Dacic S; Lantuejoul S; Russell PA; den Bakker M; Botling J; Brambilla E; de Cuba E; Geisinger KR; Hiroshima K; Marchevsky AM; Minami Y; Moreira A; Nicholson AG; Yoshida A; Tsao MS; Warth A; Duhig E; Chen G; Matsuno Y; Travis WD; Butnor K; Cooper W; Mino-Kenudson M; Motoi N; Poleri C; Pelosi G; Kerr K; Aisner SC; Ishikawa Y; Buettner RH; Keino N; Yatabe Y; Noguchi M
J Thorac Oncol; 2017 Feb; 12(2):334-346. PubMed ID: 27998793
[TBL] [Abstract][Full Text] [Related]
39. Optimizing Tissue Use: A Step-wise Approach to Diagnosing Squamous Cell Lung Carcinoma on Small Biopsies.
Olazagasti C; Preeshagul I; Aziz M; Seetharamu N
Clin Pathol; 2020; 13():2632010X20921873. PubMed ID: 32548580
[TBL] [Abstract][Full Text] [Related]
40. Value of cytology in small cell lung carcinoma diagnostic--single-center study.
Milicić V; Prvulović I; Misić M; Perić M; Samardzić S; Tomić K
Coll Antropol; 2014 Jun; 38(2):611-6. PubMed ID: 25144997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
